Journal of Istanbul Faculty of Medicine

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IUITFD.0027   IUP :10.26650/IUITFD.0027    Full Text (PDF)

COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA

Alpaslan Kaban, Samet Topuz, Hamdullah Sözen, Yavuz Salihoglu

Objective: The aim of this study was to compare the survival durations of patients with uterine carcinosarcoma with the survival of patients with serous endometrial cancer. 

Method: Patients who were operated for endometrial cancer between 2002 and 2014 were screened from clinic archive. Patients with histological tumor type carcinosarcoma or serous type were included in the study. 

Results: Total number of patients was 99; 53 of them had carcinosarcoma and 46 had serous histology. Median disease-free survival was 20 (2-27) months in carcinosarcoma and 36 (3-180) months in serous type (Log-Rank test p=0.156). Median overall survival duration was 28 (4-170) months for carcinosarcoma and 46 (3-180) months for serous (p=0.105). The 5-year overall survival rate was 41.2% in carcinosarcoma histology and 55.4% in serous histology. After recurrence, patients with carcinosarcoma histology survived for an average of 8 (1-19) months, while those with serous histology survived for an average of 14 (2-43) months (p=0.090). 

Conclusion: According to the results of Log-Rank test analysis, no statistically significant survival difference between the patients with uterin carcinosarcoma and with serous endometrial cancer was found. However, disease-free survival, overall survival, and survival duration after recurrence are longer in serous histology than in carcinosarcoma. 
Keywords: Endometrium cancer, survival, carcinoma, carcinosarcoma
DOI :10.26650/IUITFD.0027   IUP :10.26650/IUITFD.0027    Full Text (PDF)

SERÖZ ENDOMETRİAL KANSER VE UTERİN KARSİNOSARKOMDA GENEL SAĞKALIM VE HASTALIKSIZ SAĞKALIMIN KARŞILAŞTIRILMASI

Alpaslan Kaban, Samet Topuz, Hamdullah Sözen, Yavuz Salihoglu

Amaç: Bu çalışmanın amacı uterin karsinosarkomlu hastaların yaşam süresini, seröz endometrial kanserli hastaların yaşam süreleri ile karşılaştırmaktı. 

Yöntem: 2002-2014 yılları arasında endometriyal kanser nedeniyle opere edilen hastalar klinik arşivinden tarandı. Çalışmaya histolojik tümör tipi karsinosarkom veya seröz tip olan hastalar dahil edildi. 

Bulgular: Toplam hasta sayısı 99; bunların 53’ünde karsinosarkom, 46’sında seröz histoloji saptandı. Medyan hastalıksız sağkalım süresi karsinosarkomda 20 (2-27) ay ve seröz tipte 36 (3-180) aydı (Log-Rank testi p=0,156). Medyan sağkalım süresi karsinosarkom için 28 (4-170) ay, seröz için 46 (3-180) aydı (p=0,105). Beş yıllık genel sağkalım oranı, karsinosarkom histolojisinde %41,2 iken, seröz histolojide %55,4 idi. Nüksten sonra, karsinosarkom histolojisi olan hastalar ortalama 8 (1-19) ay, seröz histolojisi olanlar ortalama 14 (2-43 ay) yaşamışlardı (p=0,090). 

Sonuç: Log-Rank test analizi sonuçlarına göre, uterin karsinosarkomlu ve seröz endometriyal kanserli hastalar arasında istatistiksel olarak anlamlı bir sağkalım farkı bulunmadı. Bununla birlikte, hastalıksız sağkalım, genel sağkalım ve nüks sonrası sağkalım süresi seröz histolojide karsinosarkomdan daha uzundur. 
Keywords: Endometrium kanseri, sağkalım, karsinom, karsinosarkom

PDF View

References

  • 1. Moore KN, Fader AN. Uterine papillary serous carcinoma. Clin Obstet Gynecol 2011;54(2):278–91. google scholar
  • 2. Ferrandina G, Zannoni GF, Martinelli E, Vellone V, Prisco MG, Scambia G. Endometrial carcinoma recurring as carcinosarcoma: Report of two cases. Pathol Res Pract 2007;203(9):677–81. google scholar
  • 3. NCCN. NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. Nccn. 2015; https://www.nccn.org/professionals/physician_gls/default.aspx google scholar
  • 4. Spaziani E, Picchio M, Petrozza V, Briganti M, Ceci F, Di Filippo A, et al. Carcinosarcoma of the uterus: A case report and review of the literature. Eur J Gynaecol Oncol 2008;29(5):531–4. google scholar
  • 5. Singh R. Review literature on uterine carcinosarcoma. J Cancer Res Ther 2014;10(3):461–8. google scholar
  • 6. Zhang C, Hu W, Jia N, Li Q, Hua K, Tao X, et al. Uterine carcinosarcoma and high-risk endometrial carcinomas: A clinicopathological comparison. Int J Gynecol cancer 2015;25(30973185):629–36. google scholar
  • 7. Piver MS, Lele SB, Marchetti DL, Emrich LJ. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. J Surg Oncol 1988;38(4):233–9. google scholar
  • 8. Gadducci A, Fabrini MG, Facchini V, Ducci F, Colosimo S, Dell’Arciprete T, et al. Surgery and radiotherapy in the treatment of early stage uterine sarcomas. Eur J Gynaecol Oncol 1989;10(4):276–80. google scholar
  • 9. Hamilton C, Cheung M, Osann K, Chen L, Teng N, Longacre T, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 2006;94(5):642–6. google scholar
  • 10. Üreyen I, Karalok A, Cırık DA, Taşçı T, Türkmen O, Cömert GK, et al. A comparison of clinico-pathologic characteristics of patients with serous and clear cell carcinoma of the uterus. Turk J Obs Gynecol 2016;13(3):137–43. google scholar
  • 11. Felix AS, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, et al. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. Int J Gynecol Cancer 2011;21(5):877–84. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Kaban, A., Topuz, S., Sözen, H., & Salihoglu, Y. (2019). COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA. Journal of Istanbul Faculty of Medicine, 82(1), 1-4. https://doi.org/10.26650/IUITFD.0027


AMA

Kaban A, Topuz S, Sözen H, Salihoglu Y. COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA. Journal of Istanbul Faculty of Medicine. 2019;82(1):1-4. https://doi.org/10.26650/IUITFD.0027


ABNT

Kaban, A.; Topuz, S.; Sözen, H.; Salihoglu, Y. COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 82, n. 1, p. 1-4, 2019.


Chicago: Author-Date Style

Kaban, Alpaslan, and Samet Topuz and Hamdullah Sözen and Yavuz Salihoglu. 2019. “COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA.” Journal of Istanbul Faculty of Medicine 82, no. 1: 1-4. https://doi.org/10.26650/IUITFD.0027


Chicago: Humanities Style

Kaban, Alpaslan, and Samet Topuz and Hamdullah Sözen and Yavuz Salihoglu. “COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA.” Journal of Istanbul Faculty of Medicine 82, no. 1 (Jun. 2025): 1-4. https://doi.org/10.26650/IUITFD.0027


Harvard: Australian Style

Kaban, A & Topuz, S & Sözen, H & Salihoglu, Y 2019, 'COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA', Journal of Istanbul Faculty of Medicine, vol. 82, no. 1, pp. 1-4, viewed 26 Jun. 2025, https://doi.org/10.26650/IUITFD.0027


Harvard: Author-Date Style

Kaban, A. and Topuz, S. and Sözen, H. and Salihoglu, Y. (2019) ‘COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA’, Journal of Istanbul Faculty of Medicine, 82(1), pp. 1-4. https://doi.org/10.26650/IUITFD.0027 (26 Jun. 2025).


MLA

Kaban, Alpaslan, and Samet Topuz and Hamdullah Sözen and Yavuz Salihoglu. “COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA.” Journal of Istanbul Faculty of Medicine, vol. 82, no. 1, 2019, pp. 1-4. [Database Container], https://doi.org/10.26650/IUITFD.0027


Vancouver

Kaban A, Topuz S, Sözen H, Salihoglu Y. COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA. Journal of Istanbul Faculty of Medicine [Internet]. 26 Jun. 2025 [cited 26 Jun. 2025];82(1):1-4. Available from: https://doi.org/10.26650/IUITFD.0027 doi: 10.26650/IUITFD.0027


ISNAD

Kaban, Alpaslan - Topuz, Samet - Sözen, Hamdullah - Salihoglu, Yavuz. “COMPARISON OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN SEROUS ENDOMETRIAL CANCER AND UTERINE CARCINOSARCOMA”. Journal of Istanbul Faculty of Medicine 82/1 (Jun. 2025): 1-4. https://doi.org/10.26650/IUITFD.0027



TIMELINE


Submitted19.11.2018
Accepted30.01.2019
Published Online28.03.2019

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE



Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.